The transaction, first announced on June 12, forecasts enhanced earnings in the first year upon completion.
Biomin, a specialty animal nutrition and health business, specializes primarily in mycotoxin risk management and gut health performance. The acquisition of Biomin further strengthens DSM’s expertise and reputation as a leading provider of animal health and nutrition solutions for farm productivity and sustainability, with an emphasis on emissions reduction, feed consumption efficiency, and better use of water and land. It is therefore aligned closely with DSM’s focus to make animal farming more sustainable from both an ecological and economical perspective.
The Romer Labs business focuses on food and feed safety diagnostic solutions. Romer Labs also complements DSM’s human nutrition and health offering to customers in the food and beverage market segments. Both entities expand DSM’s range of higher value-added specialty solutions. 
—From a Biomin news release
